Visit JCR Japan

Visit JCR Japan

Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Italfarmaco and JCR Pharmaceuticals announce commercialisation agreement for Givinostat in Japan and strategic collaboration in rare disease

December 24, 2025

|In News

Back to Newsroom

Sitemap
Compliance
Privacy policy
Global policy
Cookie policy
Cookie settings

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Privacy Preference Center

Privacy Preferences